publication venue for
- CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study. 2023
- TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. 2023
- TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer.. 17. 2025
- Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.. 15. 2023
- Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma.. 13. 2021
- Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer.. 11. 2019
- Bevacizumab in metastatic breast cancer: when may it be used?. 3. 2011
- Reassessing the need for primary tumor surgery in unresectable metastatic colorectal cancer: overview and perspective.. 3. 2011
- Long-term survival in a patient with glioblastoma on antipsychotic therapy for schizophrenia: a case report and literature review. 2016
- Radiotherapy and checkpoint inhibitors: a winning new combination? 2018